Tumor-induced osteomalacia: Clinical and basic studies

被引:52
作者
Shane, E
Parisien, M
Henderson, JE
Dempster, DW
Feldman, F
Hardy, MA
Tohme, JF
Karaplis, AC
Clemens, TL
机构
[1] COLUMBIA UNIV COLL PHYS & SURG, DEPT PATHOL, NEW YORK, NY 10032 USA
[2] COLUMBIA UNIV COLL PHYS & SURG, DEPT RADIOL, NEW YORK, NY 10032 USA
[3] COLUMBIA UNIV COLL PHYS & SURG, DEPT SURG, NEW YORK, NY 10032 USA
[4] MCGILL UNIV, LADY DAVIS INST MED RES, MONTREAL, PQ, CANADA
[5] HELEN HAYES HOSP, REG BONE CTR, W HAVERSTRAW, NY USA
[6] UNIV CINCINNATI, COLL MED, CINCINNATI, OH USA
关键词
D O I
10.1359/jbmr.1997.12.9.1502
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A patient with classic clinical and biochemical features of tumor-induced osteomalacia (hypophosphatemia, phosphaturia, and undetectable serum concentrations of 1,25-dihydroxyvitamin D [1,25(OH)(2)D]) was studied before and after resection of a benign extraskeletal chondroma from the plantar surface of the foot, Presurgical laboratory evaluation was notable for normal serum concentrations of calcium, intact parathyroid hormone (PTH), parathyroid hormone-related protein (PTHrP), and osteocalcin, increased serum alkaline phosphatase activity, and frankly elevated urinary cyclic adenosine monophosphate (cAMP) and pyridinium cross-link excretion, Quantitative histomorphometry showed severe osteomalacia and deep erosions of the cancellous surface by active osteoclasts. After resection, serum 1,25(OH)(2)D normalized within 24 h, while renal tubular phosphorus reabsorption and serum phosphorus did not normalize until days 2 and 3, respectively; serum Ca declined slightly, and serum intact PTH, osteocalcin, and urinary pyridinium cross-link excretion increased dramatically, Urinary cAMP excretion declined immediately after resection and then began to increase concomitant with the increase in serum intact PTH, A second bone biopsy taken 3 months after resection demonstrated complete resolution of the osteomalacia, increased mineral apposition rate (1.09 mu/day), resorption surface (9.2%), mineralizing surface (71%), and bone formation rate (0.83 mm(3)/mm(2)/day), and marked decreases in cancellous bone volume (13.1%) and trabecular connectivity compared with the first biopsy, Tumor extracts did not affect phosphate transport in renal epithelial cell lines or 1 alpha-hydroxylase activity in a myelomonocytic cell line, The patient's course suggests that the abnormal 1,25(OH)(2)D and phosphorus metabolism is due to a tumor product that may be acting via stimulation of adenylate cyclase activity, Increased bone resorption prior to surgical resection suggests that the tumor may also produce an osteoclast activator, The rise in resorption surface and pyridinium cross-link excretion, increase in serum osteocalcin and bone mineralization, normalization of osteoid width, and fall in cancellous bone volume after resection are consistent with healing of osteomalacia by rapid remodeling.
引用
收藏
页码:1502 / 1511
页数:10
相关论文
共 57 条
  • [1] ADAMS JS, 1990, J BONE MINER RES, V5, P1265
  • [2] FACTORS THAT PROMOTE PROGRESSIVE DEVELOPMENT OF THE OSTEOBLAST PHENOTYPE IN CULTURED FETAL-RAT CALVARIA CELLS
    ARONOW, MA
    GERSTENFELD, LC
    OWEN, TA
    TASSINARI, MS
    STEIN, GS
    LIAN, JB
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 1990, 143 (02) : 213 - 221
  • [3] VITAMIN-D-RESISTANT RICKETS ASSOCIATED WITH EPIDERMAL NEVUS SYNDROME - DEMONSTRATION OF A PHOSPHATURIC SUBSTANCE IN DERMAL LESIONS
    ASCHINBERG, LC
    SOLOMON, LM
    ZEIS, PM
    JUSTICE, P
    ROSENTHAL, IM
    [J]. JOURNAL OF PEDIATRICS, 1977, 91 (01) : 56 - 60
  • [4] BIJVOET OLM, 1980, RENAL HANDLING PHOSP, P1
  • [5] BRONCKERS ALJJ, 1987, BONE MINER, V2, P361
  • [6] IMMUNOCHEMICAL CHARACTERIZATION OF CIRCULATING PARATHYROID-HORMONE RELATED PROTEIN IN PATIENTS WITH HUMORAL HYPERCALCEMIA OF CANCER
    BURTIS, WJ
    BRADY, TG
    ORLOFF, JJ
    ERSBAK, JB
    WARRELL, RP
    OLSON, BR
    WU, TL
    MITNICK, ME
    BROADUS, AE
    STEWART, AF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (16) : 1106 - 1112
  • [7] INHIBITION OF RENAL PHOSPHATE-TRANSPORT BY A TUMOR PRODUCT IN A PATIENT WITH ONCOGENIC OSTEOMALACIA
    CAI, Q
    HODGSON, SF
    KAO, PC
    LENNON, VA
    KLEE, GG
    ZINSMIESTER, AR
    KUMAR, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (23) : 1645 - 1649
  • [8] OSTEOMALACIA SECONDARY TO OSTEO-SARCOMA - A CASE-REPORT
    CHENG, CL
    MA, J
    WU, PC
    MASON, RS
    POSEN, S
    [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1989, 71A (02) : 288 - 292
  • [9] Changes in quantitative bone histomorphometry in aging healthy men
    Clarke, BL
    Ebeling, PR
    Jones, JD
    Wahner, HW
    OFallon, WM
    Riggs, BL
    Fitzpatrick, LA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (06) : 2264 - 2270
  • [10] CLONAL SUBLINES THAT ARE MORPHOLOGICALLY AND FUNCTIONALLY DISTINCT FROM PARENTAL OK CELLS
    COLE, JA
    FORTE, LR
    KRAUSE, WJ
    THORNE, PK
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 256 (04): : F672 - F679